Healthy Skepticism Library item: 6567

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Sandoz claims that for suppressing lactation “Parlodel is still the most extensively studied, the most effective and the one with the most favourable ratio of benefit to risk”
MaLAM International News 1995 Jan; 13:(1):1-2

Abstract:

Sandoz has withdrawn the indication of postpartum lactation suppression in Canada and the United States but continues to market the drug for this indication in the rest of the world. The company justifies its decision by claiming that a causal relationship with adverse effects has never been proven.

Keywords:
*analysis/Pakistan/Canada/United States/developing countries/developed countries/Parlodel/Sandoz/quality of information/ lactation suppression/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: BREAST FEEDING AND CONTRACEPTION